Bioethics FDA Featured Health Law Policy History Intellectual Property Pharmaceuticals Professional Regulation Public Health Reimbursement Research Funding Resource Allocation Vaccines Reasonable Pricing Clauses: A First Step Toward Ensuring Taxpayers a Fair Return on their Public R&D Investment Read more: Reasonable Pricing Clauses: A First Step Toward Ensuring Taxpayers a Fair Return on their Public R&D Investment
Patient Care Pharmaceuticals Public Health Law Research Reimbursement Social Determinants of Health Many Hospitals Receiving Discounted Drugs May Not Offer Patients Pharmaceutical Assistance Read more: Many Hospitals Receiving Discounted Drugs May Not Offer Patients Pharmaceutical Assistance
Antitrust Featured Generic Drugs Greg Curfman Health Law Policy Intellectual Property Pharmaceuticals Public Health 3 Challenges to Patents on Therapeutic Monoclonal Antibodies Read more: 3 Challenges to Patents on Therapeutic Monoclonal Antibodies
Antitrust Generic Drugs Health Law Policy Intellectual Property Pharmaceuticals Public Health AbbVie Wins First Round in Humira Antitrust Lawsuit Read more: AbbVie Wins First Round in Humira Antitrust Lawsuit
Bioethics FDA Featured Health Law Policy History HIV/AIDS Intellectual Property Jorge Contreras Pharmaceuticals Public Health What Ever Happened to NIH’s “Fair Pricing” Clause? Read more: What Ever Happened to NIH’s “Fair Pricing” Clause?
Antitrust Beatrice Brown Bioethics Empirical Generic Drugs Health Care Reform Health Law Policy Intellectual Property Pharmaceuticals Public Health To Cut Prescription Drug Spending, Stop Delays for Generic Competition Read more: To Cut Prescription Drug Spending, Stop Delays for Generic Competition
Bioethics Health Law Policy International Pharmaceuticals Public Health How Do We Arrive at Fair Pricing for COVID-19 Therapies? Read more: How Do We Arrive at Fair Pricing for COVID-19 Therapies?